1. Objective To find the detecting method of erythropoietin ( EPO ).

2. BACKGROUND: Recombinant human erythropoietin is commonly used for treatment of anaemia.

3. Objective : To evaluate the efficacy of erythropoietin in prevention of prematurity anemia.

3.

4. The pathogenesis related to the erythropoietin secretion from malignant tumors, while another factor might be the immunological disturbance of T-lymphocyte caused by thymoma.

5. Objective : To study the use of erythropoietin receptor ( EPOR ) in anemia of chronic renal failure.

6. One popular drug, the hormone erythropoietin (EPO), has been shown to increase the peak power output of healthy volunteers by 16 per cent after four weeks of taking the drug.

7. Objective: To determine the effect of erythropoietin ( EP ) on the proliferation of mesenchymal stem cells ( MSCs ) in vitro.

8. Aim : To evaluate the erythropoietin ( EPO ) expression in posterior fossa hemangioblastomas ( HBs ) and their clinical value.

9. Objective To investigate the effect of Erythropoietin(EPO) on the lipid peroxydase(LPO) and superoxide dismutase(SOD) in peripheral blood of traumatic brain injury (TBI)patients.

10. The article reviews the development of erythropoietin and its receptors, structure and protective mechanism in retina.

11. The drug erythropoietin ( EPO ) provides a good example.

12. Objective To explore erythropoietin(EPO) and ferrous sulfate therapy used to autohemotherapy(AHT) in the child cardiac operation.

13. Recently, it has been stated that erythropoietin ( EPO ) has a wide range of non - erythropoietic functions.

14. Erythropoiesis is regulated by erythropoietin, which increases in the presence of hypoxia and regulates RBC production.

15. The results demonstrate that erythropoietin could a key role in the battle against malaria.

16. Moreover, erythroid colonies could be grown from blood samples without the need for exogenous erythropoietin.

17. Objective To observe the curative effect of with L - carnitine and erythropoietin in hemodialysis patients with anemia.

18. The has approved a test the use of the banned synthetic hormone erythropoietin , or EPO.

19. This invention relates to a solution preparation of recombinant human erythropoietin.

20. Results: Show the dose, methods and effects of recombinant human erythropoietin to premature infants with anemia.

21. Objective: To investigate in vitro release characteristics of collagen double layer minipellet of erythropoietin ( EPO ) .

22. Features of the related myeloproliferative disorder included isolated erythrocytosis, distinctive bone marrow morphology, and reduced serum erythropoietin levels.

23. Moreoer, erythroid colonies could be grown from blood samples without the need for exogenous erythropoietin.

24. Hemoglobin concentration and the number of reticulocyte decreased greatly, while serum erythropoietin (EPO) level increased significantly.

25. CONCLUSION The jel method of bacterial endotoxin test can be used to pyrogen test the endotoxin in recombinant human erythropoietin injection instead of rabbit.

26. Objective To observe the curative effect of with L - carnitine and erythropoietin with anemia.

27. Released kidney lysosomal enzymes may be concerned in the generation of erythropoietin.

28. ConclusionAnemia is not related with iron metabolism in vivo in patients who has urinemia, the main reason is lacking of erythropoietin.

29. If symptoms become severe, a blood transfusion or injections of synthetic erythropoietin, a hormone normally produced by your kidneys, may help stimulate red blood cell production and ease fatigue.